Delivery Order SPE2DR25D7065-SPE2DR26F8GDD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,109.54 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on January 7, 2026, with an ultimate completion date of January 8, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a specific task order under a larger vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,749.81 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competed, firm fixed price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a single execution against AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form, valued at $1,246.38 under a firm fixed price contract type. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,903.90 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 25, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,124.67 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. The contract is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and was competitively awarded without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $157,329.97. This is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and represents a non-set-aside, competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $2,705.28 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. The contract, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $11,153.57 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $47,667.15 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $108,249.16 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, reflecting AmerisourceBergen's demonstrated capability to compete successfully...
- SPE2DR25D7065Indefinite Delivery Contract
- SPE2DR25D7065-SPE2DR26F8GDDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,434.52 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on January 7, 2026, with an ultimate completion date of January 8, 2026. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and related military healthcare systems. The company maintains a significant IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the contracting vehicle for this and similar pharmaceutical supply deliveries. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in supplying vaccines, brand-name and generic medications, medical devices, and specialized healthcare commodities to support military treatment facilities and government healthcare programs worldwide. No set-aside designation was applied to this award, indicating it was awarded through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/6/26 |